Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention
Helicobacter pylori (H. pylori), a globally prevalent pathogen Group I carcinogen, presents a formidable challenge in gastric cancer prevention due to its increasing antimicrobial resistance and strain diversity. This comprehensive review critically analyzes the limitations of conventional antibioti...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1500921/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850266133905539072 |
|---|---|
| author | Zhiwei Tu Youtao Wang Junze Liang Jinping Liu |
| author_facet | Zhiwei Tu Youtao Wang Junze Liang Jinping Liu |
| author_sort | Zhiwei Tu |
| collection | DOAJ |
| description | Helicobacter pylori (H. pylori), a globally prevalent pathogen Group I carcinogen, presents a formidable challenge in gastric cancer prevention due to its increasing antimicrobial resistance and strain diversity. This comprehensive review critically analyzes the limitations of conventional antibiotic-based therapies and explores cutting-edge approaches to combat H. pylori infections and associated gastric carcinogenesis. We emphasize the pressing need for innovative therapeutic strategies, with a particular focus on precision medicine and tailored vaccine development. Despite promising advancements in enhancing host immunity, current Helicobacter pylori vaccine clinical trials have yet to achieve long-term efficacy or gain approval regulatory approval. We propose a paradigm-shifting approach leveraging artificial intelligence (AI) to design precision-targeted, multiepitope vaccines tailored to multiple H. pylori subtypes. This AI-driven strategy has the potential to revolutionize antigen selection and optimize vaccine efficacy, addressing the critical need for personalized interventions in H. pylori eradication efforts. By leveraging AI in vaccine design, we propose a revolutionary approach to precision therapy that could significantly reduce H. pylori -associated gastric cancer burden. |
| format | Article |
| id | doaj-art-a69beb57a3cb49fcb005129cd34d3846 |
| institution | OA Journals |
| issn | 1664-3224 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-a69beb57a3cb49fcb005129cd34d38462025-08-20T01:54:15ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-11-011510.3389/fimmu.2024.15009211500921Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer preventionZhiwei TuYoutao WangJunze LiangJinping LiuHelicobacter pylori (H. pylori), a globally prevalent pathogen Group I carcinogen, presents a formidable challenge in gastric cancer prevention due to its increasing antimicrobial resistance and strain diversity. This comprehensive review critically analyzes the limitations of conventional antibiotic-based therapies and explores cutting-edge approaches to combat H. pylori infections and associated gastric carcinogenesis. We emphasize the pressing need for innovative therapeutic strategies, with a particular focus on precision medicine and tailored vaccine development. Despite promising advancements in enhancing host immunity, current Helicobacter pylori vaccine clinical trials have yet to achieve long-term efficacy or gain approval regulatory approval. We propose a paradigm-shifting approach leveraging artificial intelligence (AI) to design precision-targeted, multiepitope vaccines tailored to multiple H. pylori subtypes. This AI-driven strategy has the potential to revolutionize antigen selection and optimize vaccine efficacy, addressing the critical need for personalized interventions in H. pylori eradication efforts. By leveraging AI in vaccine design, we propose a revolutionary approach to precision therapy that could significantly reduce H. pylori -associated gastric cancer burden.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1500921/fullgastric cancerHelicobacter pyloriprecision medicinetargeted therapyneoantigen vaccinesartificial intelligence |
| spellingShingle | Zhiwei Tu Youtao Wang Junze Liang Jinping Liu Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention Frontiers in Immunology gastric cancer Helicobacter pylori precision medicine targeted therapy neoantigen vaccines artificial intelligence |
| title | Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention |
| title_full | Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention |
| title_fullStr | Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention |
| title_full_unstemmed | Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention |
| title_short | Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention |
| title_sort | helicobacter pylori targeted ai driven vaccines a paradigm shift in gastric cancer prevention |
| topic | gastric cancer Helicobacter pylori precision medicine targeted therapy neoantigen vaccines artificial intelligence |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1500921/full |
| work_keys_str_mv | AT zhiweitu helicobacterpyloritargetedaidrivenvaccinesaparadigmshiftingastriccancerprevention AT youtaowang helicobacterpyloritargetedaidrivenvaccinesaparadigmshiftingastriccancerprevention AT junzeliang helicobacterpyloritargetedaidrivenvaccinesaparadigmshiftingastriccancerprevention AT jinpingliu helicobacterpyloritargetedaidrivenvaccinesaparadigmshiftingastriccancerprevention |